A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
about
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisChronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical featuresA scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data.Eosinophilic myeloproliferative disordersRefined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalTyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Diagnosis, progression patterns and prognostication in mastocytosis.Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive.Paediatric mastocytosis: a systematic review of 1747 cases.Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.Molecular changes associated with the development of resistance to imatinib in an imatinib-sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation.The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm.How we diagnose and treat systemic mastocytosis in adults.Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia.
P2860
Q26830207-8117B4F0-232C-41D8-9BDB-9A2742677E36Q27026581-1EE8E170-F0BC-42EB-9FF3-03B32EC72025Q31082982-C0306C46-D18B-472A-9130-097D8800B67EQ33881283-D505E4D4-CB58-442F-92D3-B2A0300A8A63Q34137971-8990E4CF-79E2-41C8-A86E-8071DCCF327DQ34495630-BFEC6071-0721-4912-9516-31FC319B1B62Q35153623-9EEF0064-77E7-4EDC-85D8-D4B08A99ABE8Q38025156-0F0BE0AA-DCE6-4474-A1B3-D4CA6E07DD60Q38045311-D27E1A6B-9215-4BA8-ACA1-B4C91C5F6C92Q38348047-76288066-4724-4B75-B95F-246532A80207Q38905860-6941649A-D056-4205-BAF6-293F5CE1932CQ38909315-E38023C8-E712-411B-8246-76BE57D4A363Q42234623-4831953C-0BBA-401D-A0E4-B996E177049FQ47763014-8DBBD3C4-D18B-4804-9D47-6C918ABF9E80Q52884801-7286B5F9-F1D8-4930-B100-BE2BD1650D56Q54530545-1EB76F73-8152-48ED-9D9C-909AEF7EAE42Q55286285-E70B87FE-70D3-4A29-BA63-B610A4D5DD41
P2860
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
@en
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
@nl
type
label
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
@en
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
@nl
prefLabel
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
@en
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
@nl
P2093
P2860
P1476
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
@en
P2093
Andrzej Hellmann
Anna Piskorz
Bartosz Wasąg
Krzysztof Lewandowski
P2860
P304
P356
10.1111/J.1600-0609.2011.01598.X
P577
2011-04-07T00:00:00Z